You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 43 No. 11, November 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (55)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

{alpha}2Adrenergic and Opiate Receptor Blockade

Synergistic Effects on Anxiety in Healthy Subjects

Dennis S. Charney, MD; George R. Heninger, MD

Arch Gen Psychiatry. 1986;43(11):1037-1041.


Abstract



• To evaluate interactions between the opiate and adrenergic systems in healthy humans, concomitant administration of the opiate antagonist, naloxone hydrochloride, and the {alpha}2-adrenergic receptor antagonist, yohimbine hydrochloride, was compared with the administration of placebo and of each drug separately. A synergistic effect of the combination (larger than the sum of the effects of the two drugs separately) was observed on subject ratings of nervousness, anxiety, tremors, palpitations, nausea, hot and cold flashes, and increased plasma cortisol concentrations. In addition, following the combination, each of the male subjects studied reported a full penile erection lasting at least 60 minutes, an effect not reported when each drug was given separately. These results demonstrate that interactions between the opiate the adrenergic systems have important implications for our understanding of the cause and treatment of anxiety disorders and male impotence.



Author Affiliations



From the Clinical Neuroscience Research Unit, Ribicoff Research Facilities, Connecticut Mental Health Center, and the Department of Psychiatry, Yale University School of Medicine, New Haven.


Footnotes



Accepted for publication Dec 6, 1985.

Reprint requests to Clinical Neuroscience Research Unit, Connecticut Mental Health Center, 34 Park St, New Haven, CT 06508 (Dr Charney).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Opioids and anxiety
Colasanti et al.
J Psychopharmacol 2011;25:1415-1433.
ABSTRACT | FULL TEXT  

The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies
Kalk et al.
J Psychopharmacol 2011;25:3-16.
ABSTRACT  

The endocrinology of sexual arousal
Bancroft
J Endocrinol 2005;186:411-427.
ABSTRACT | FULL TEXT  

Pharmacology of Penile Erection
Andersson
Pharmacol. Rev. 2001;53:417-450.
ABSTRACT | FULL TEXT  

Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment
Kandeel et al.
Endocr Rev 2001;22:342-388.
ABSTRACT | FULL TEXT  

The Neurobiology of Sexual Function
Meston and Frohlich
Arch Gen Psychiatry 2000;57:1012-1030.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.